Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

References

• Chlibek R , Pauksens K , Rombo L , van Rijckevorsel G , Richardus JH , Plassmann G , Schwarz TF , Catteau G , Lal H , Heineman TC. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults. Vaccine 2016; 34:863-8; PMID:26432913; https://doi.org/10.1016/j.vaccine.2015.09.073
   PubMed Web of Science ®Google Scholar
• CDC . Shingles (Herpes Zoster). [accessed 2017 June 15 ]. http://www.cdc.gov/shingles/hcp/clinical-overview.html
   Google Scholar
• Katz J , Cooper EM , Walther RR , Sweeney EW , Dworkin RH . Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004; 39:342-8; PMID:15307000; https://doi.org/10.1086/421942
   PubMed Web of Science ®Google Scholar
• Gater A , Abetz-Webb L , Carroll S , Mannan A , Serpell M , Johnson R . Burden of herpes zoster in the UK: Findings from the zoster quality of life (ZQOL) study. BMC Infect Dis 2014; 14:402; PMID:25038799; https://doi.org/10.1186/1471-2334-14-402
   PubMed Web of Science ®Google Scholar
• Katz J , Melzack R . Measurement of pain. Surg Clin North Am 1999; 79:231-52; PMID:10352653; https://doi.org/10.1016/S0039-6109(05)70381-9
   PubMed Web of Science ®Google Scholar
• Johnson RW , Wasner G , Saddier P , Baron R . Postherpetic neuralgia: Epidemiology, pathophysiology and management. Expert Rev Neurother 2007; 7:1581-95; PMID:17997705; https://doi.org/10.1586/14737175.7.11.1581
   PubMedGoogle Scholar
• Volpi A . Severe complications of herpes zoster. Herpes 2007; 14(Suppl 2):35-9; PMID:17939894
   PubMedGoogle Scholar
• Dworkin RH , Johnson RW , Breuer J , Gnann JW , Levin MJ , Backonja M , Betts RF , Gershon AA , Haanpaa ML , McKendrick MW , et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1):S1-26; PMID:17143845; https://doi.org/10.1086/510206
   PubMed Web of Science ®Google Scholar
• Johnson RW , Bouhassira D , Kassianos G , Leplege A , Schmader KE , Weinke T . The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37; PMID:20565946; https://doi.org/10.1186/1741-7015-8-37
   PubMed Web of Science ®Google Scholar
• Ultsch B , Siedler A , Rieck T , Reinhold T , Krause G , Wichmann O . Herpes zoster in Germany: Quantifying the burden of disease. BMC Infect Dis 2011; 11:173; PMID:21679419; https://doi.org/10.1186/1471-2334-11-173
   PubMed Web of Science ®Google Scholar
• Ultsch B , Weidemann F , Reinhold T , Siedler A , Krause G , Wichmann O . Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res 2013; 13:359; PMID:24070414; https://doi.org/10.1186/1472-6963-13-359
   PubMed Web of Science ®Google Scholar
• Ultsch B , Koster I , Reinhold T , Siedler A , Krause G , Icks A , Schubert I , Wichmann O . Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ 2013; 14:1015-26; PMID:23271349; https://doi.org/10.1007/s10198-012-0452-1
   PubMed Web of Science ®Google Scholar
• Varghese L , Standaert B , Olivieri A , Curran D . The temporal impact of aging on the burden of herpes zoster. BMC Geriatr 2017; 17:30; PMID:28114907; https://doi.org/10.1186/s12877-017-0420-9
   PubMed Web of Science ®Google Scholar
• Oxman MN , Levin MJ , Johnson GR , Schmader KE , Straus SE , Gelb LD , Arbeit RD , Simberkoff MS , Gershon AA , Davis LE , et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84; PMID:15930418; https://doi.org/10.1056/NEJMoa051016
   PubMed Web of Science ®Google Scholar
• Schmader KE , Levin MJ , Gnann JW Jr , McNeil SA , Vesikari T , Betts RF , Keay S , Stek JE , Bundick ND , Su SC , et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis 2012; 54:922-8; PMID:22291101; https://doi.org/10.1093/cid/cir970
   PubMed Web of Science ®Google Scholar
• Vesikari T , Hardt R , Rumke HC , Icardi G , Montero J , Thomas S , Sadorge C , Fiquet A . Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax(R)) in individuals aged >/= 70 years: A randomized study of a single dose vs. two different two-dose schedules. Hum Vaccin Immunother 2013; 9:858-64; PMID:23319176; https://doi.org/10.4161/hv.23412
   PubMed Web of Science ®Google Scholar
• Lal H , Cunningham AL , Godeaux O , Chlibek R , Diez-Domingo J , Hwang SJ , Levin MJ , McElhaney JE , Poder A , Puig-Barbera J , et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015; 372:2087-96; PMID:25916341; https://doi.org/10.1056/NEJMoa1501184
   PubMed Web of Science ®Google Scholar
• Cunningham AL , Lal H , Kovac M , Chlibek R , Hwang SJ , Diez-Domingo J , Godeaux O , Levin MJ , McElhaney JE , Puig-Barbera J , et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med 2016; 375:1019-32; PMID:27626517; https://doi.org/10.1056/NEJMoa1603800
   PubMed Web of Science ®Google Scholar
• Cunningham AL . The herpes zoster subunit vaccine. Expert Opin Biol Ther 2016; 16:265-71; PMID:26865048; https://doi.org/10.1517/14712598.2016.1134481
   PubMed Web of Science ®Google Scholar
• Le P , Rothberg M . How much is it worth to prevent shingles? Using cost-effectiveness analysis to determine value-based pricing of a new herpes zoster vaccine. 38th Annual North American Meeting of the Society for Medical Decision Making 2016. [accessed 2017 June 15 ] https://smdm.confex.com/smdm/2016bc/webprogram/Paper10195.html
   Google Scholar
• Tseng HF , Harpaz R , Luo Y , Hales CM , Sy LS , Tartof SY , Bialek S , Hechter RC , Jacobsen SJ . Declining effectiveness of herpes zoster vaccine in adults aged >/= 60 years. J Infect Dis 2016; 213:1872-5; PMID:26908728; https://doi.org/10.1093/infdis/jiw047
   PubMed Web of Science ®Google Scholar
• Robert Koch Institute . Bericht zur epidemiologie der influenza in deutschland saison 2014/15. 2015. [accessed 2017 June 15 ]. https://influenza.rki.de/Saisonberichte/2014.pdf
   Google Scholar
• Zhang D , Johnson K , Newransky C , Acosta CJ . Herpes zoster vaccine coverage in older adults in the U.S., 2007–2013. AJPM 2017; 52(1):e17-23; PMID:28340974; https://doi.org/10.1016/j.amepre.2016.08.029
   PubMed Web of Science ®Google Scholar
• Public Health England . Herpes zoster (shingles) immunisation programme September 2015 to August 2016: Report for England. 2016. [accessed 2017 June 15 ]. https://www.gov.uk/government/publications/herpes-zoster-shingles-immunisation-programme-2015-to-2016-evaluation-report
   Google Scholar
• Varghese L , Curran D , Yan S , Krishnarajah S , Olivieri A . Estimating the Potential Public Health Impact of Introducing the HZ/su Vaccine in the US Population Aged = >50 Years. ID Week. 2015. [accessed 2017 June 15 ]. https://idsa.confex.com/idsa/2015/webprogram/Paper52887.html
   Google Scholar
• Varghese L , Nissen M , Olivieri A , Curran D . Public health perspective of phase III results of an investigational Herpes Zoster vaccine. Public Health Association of Australia - Communicable Disease Control Conference 2015. Brisbane, 2015:42. [accessed 2017 June 15 ]. https://www.phaa.net.au/eventsinfo/communicable-disease-control-conference-2
   Google Scholar
• Van Oorschot D , Anastassopoulou A , Schlegel K , Varghese L , von Krempelhuber A , Curran D . The public health impact of a new Herpes Zoster vaccine to the German population. Value in Health 2016; 19(7):A400-1.
   Google Scholar
• Van Oorschot D , Hunjan M , Varghese L , Canavan C , Curran D . The public health perspective of an investigational herpes zoster vaccine in the United Kingdom (UK). Value in Health 2016; 19(7):A400.
   Web of Science ®Google Scholar
• Van Oorschot D , Tavares R , Widenmaier R , Varghese L , Curran D . Forecasting the potential public health impact of introducing a new herpes zoster vaccine to the Canadian population. Canadian Immunization Conference - 12th, 2016.
   Google Scholar
• Johnson KD , Jiang Y , Goyette A , DeAngelis F , Graham J , Bresnitz E , Weiss TW . Comparing the estimated potential health impact of two herpes zoster vaccines in Ontario. Canadian Immunization Conference 2016. Ottawa, 2016:13. [accessed 2017 June 15 ]. http://cic-cci.ca/wp-content/uploads/2017/01/CIC16_posterabstracts-1.pdf
   Google Scholar
• Federal Statistical Office . (DeStatis – Statistisches Bundesamt). Values as of 31 Dec 2015. [accessed 2017 June 15 ]. https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/VorausberechnungBevoelkerung/BevoelkerungDeutschland2060_5124202159004.pdf?__blob = publicationFile
   Google Scholar
• Schiffner-Rohe J , Jow S , Lilie HM , Köster I , Schubert I . Herpes zoster in Germany. A retrospective analysis of SHI data (article in German). MMW Fortschr Med Originalien 2009; 151(Suppl 4):193-7; PMID:21595148
   PubMedGoogle Scholar
• Hillebrand K , Bricout H , Schulze-Rath R , Schink T , Garbe E . Incidence of herpes zoster and its complications in Germany, 2005-2009. J Infect 2015; 70:178-86; PMID:25230396; https://doi.org/10.1016/j.jinf.2014.08.018
   PubMed Web of Science ®Google Scholar
• Schmidt-Ott R , Schutter U , Simon J , Poulsen Nautrup B , von Krempelhuber A , Gopala K , Anastassopoulou A , Guignard A , Curran D , Matthews S , et al. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥ 50 years: a prospective study. J Infect Submitted.
   Google Scholar
• Yawn BP , Wollan PC , Kurland MJ , St Sauver JL , Saddier P . Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011; 86:88-93; PMID:21220354; https://doi.org/10.4065/mcp.2010.0618
   PubMed Web of Science ®Google Scholar
• Horn J , Damm O , Kretzschmar M , Karch A , Siedler A , Ultsch B , Weidemann F , Greiner W , Mikolaczyk R . Modellierung der Effekte des Varizellen-Impfprogramms in Deutschland. Abschlussbericht, Version 1.2. [accessed 2017 June 15 ]. http://www.rki.de/DE/Content/Infekt/Impfen/Forschungsprojekte/Varizellen-Impfung/Abschlussbericht.pdf?__blob = publicationFile
   Google Scholar
• Kawai K , Gebremeskel BG , Acosta CJ . Systematic review of incidence and complications of herpes zoster: Towards a global perspective. BMJ Open 2014; 4:e004833; PMID:24916088; https://doi.org/10.1136/bmjopen-2014-004833
   PubMed Web of Science ®Google Scholar
• Schiffner-Rohe J , Köster L , Beillat M , Lilie HM , Schubert I . Resource consumption and health care costs of Herpes zoster and postherpetic neuralgia in Germany (article in German). Gesundheitsökonomie & Qualitätsmanagement 2011; 16:216-23; https://doi.org/10.1055/s-0029-1245896
   Google Scholar
• Morrison VA , Johnson GR , Schmader KE , Levin MJ , Zhang JH , Looney DJ , Betts R , Gelb L , Guatelli JC , Harbecke R , et al. Long-term persistence of zoster vaccine efficacy. Clin Infect Dis 2015; 60:900-9; PMID:25416754; https://doi.org/10.1093/cid/ciu918
   PubMed Web of Science ®Google Scholar